Cardiology Department

The Department of Cardiovascular Medicine in our hospital is a national key clinical specialty and a leading discipline of clinical medicine in the Inner Mongolia Autonomous Region; the only national cardiovascular specialist training base in the Inner Mongolia Autonomous Region; a national clinical drug trial base; a national cardiovascular disease diagnosis and treatment base for critical, severe and difficult diseases; the National Cardiovascular Disease Clinical Medical Research Center, Inner Mongolia Autonomous Region The cardiovascular disease quality control center in the treatment area, the China Atrial Fibrillation Center Demonstration Base, the Coronary Intervention Diagnosis and Treatment Center, the China Heart Failure Center Demonstration Base, the Cardiac Rehabilitation Center Demonstration Base, the China Hypertension Compliance Center, the China Chest Pain Center, the Ministry of Health’s Arrhythmia Interventional Diagnosis and Treatment Training Base, and is the chairman unit of the Cardiovascular Disease Branch of the Inner Mongolia Medical Association; The Department of Cardiology currently has five wards, a CCU and a cardiac rehabilitation center. The hospital has 225 beds), 220 medical staff, and currently has 83 physicians (11 with doctorate degrees and 60 with master's degrees). There are 33 chief physicians and 21 deputy chief physicians. There is 1 supervisor for doctoral students and 11 supervisors for master students. The Department of Cardiology routinely carries out 1. Interventional treatment of complex coronary artery lesions, and has established a "green channel" for the rescue of patients with acute myocardial infarction around the clock. Intravascular ultrasound, optical coherence tomography and pressure measurement as well as coronary rotational atherectomy and shock wave therapy were performed.Including interventional treatment strategy optimization and technological innovation for chronic total occlusion (CTO) lesions, severe calcified lesions, left main trunk, bifurcation lesions, and severe three-vessel lesions. 2. Arrhythmia diagnosis and treatment: diagnosis and treatment of arrhythmia diseases such as atrial fibrillation, premature ventricular tachycardia, ventricular tachycardia, and supraventricular tachycardia. Pacemaker treatment and follow-up for sick sinus syndrome, atrioventricular block, etc. 3. Diagnosis and treatment of structural heart disease (congenital heart disease, valvular disease): transcatheter occlusion treatment of atrial septal defect, ventricular septal defect, patent ductus arteriosus, interventional diagnosis and treatment of adult complex congenital heart disease and valvular disease, chemical ablation of ventricular septal hypertrophy, etc. as well as percutaneous aortic valve implantation (TAVR) and mitral valve clamping (MitraClip). 4. Diagnosis and treatment of heart failure, myocarditis, and cardiomyopathy: diagnosis and personalized treatment of viral myocarditis, dilated cardiomyopathy, chronic heart failure, etc. Cardiac synchronization therapy (CRT), HiP system pacing therapy and CCM therapy for chronic heart failure are routinely carried out. 5. Diagnosis and treatment of pulmonary hypertension, right heart catheterization, targeted drug therapy and pulmonary artery desympathetic denervation interventional diagnosis and treatment; diagnosis, treatment and follow-up guidance for hyperlipidemia.Diagnosis and treatment of hypertensive disease, and renal artery sympathetic nerve ablation for refractory hypertension. 6. Carry out health education activities on coronary heart disease, hypertension and hyperlipidemia all year round. In 2024, the number of cardiology outpatient visits will exceed 120,000, the number of inpatients will exceed 12,000, the annual number of coronary interventional surgeries will exceed 10,000, and the number of interventional diagnosis and treatment of arrhythmias will exceed 1,000. More than 300 cases of structural heart disease.